Header Logo

Connection

David Smelson to Opioid-Related Disorders

Back to Details
This is a "connection" page, showing publications David Smelson has written about Opioid-Related Disorders.
David Smelson
Connection Strength
2.845
Opioid-Related Disorders
  1. Helm A, Shaffer P, Gonzalez G, Li W, Olmstead T, Berlowitz D, Epstein E, Smelson D. Protocol of a randomized controlled trial examining psychosocial enhancement and standard medication treatment for co-occurring opioid use and mental health disorders: A half fractional factorial randomized controlled trial. Contemp Clin Trials. 2024 Oct; 145:107668.
    View in: PubMed
    Score: 0.562
  2. Gaba A, Helm A, Shaffer PM, Pridgen B, Drawbridge D, Smelson D. Community reentry: Racial/ethnic differences in unmet needs among adults with co-occurring opioid use and mental health disorder. Int J Law Psychiatry. 2023 Nov-Dec; 91:101924.
    View in: PubMed
    Score: 0.526
  3. Jasuja GK, Ameli O, Miller DR, Land T, Bernson D, Rose AJ, Berlowitz DR, Smelson DA. Overdose risk for veterans receiving opioids from multiple sources. Am J Manag Care. 2018 11; 24(11):536-540.
    View in: PubMed
    Score: 0.376
  4. Suzuki J, Martin B, Loguidice F, Smelson D, Liebschutz JM, Schnipper JL, Weiss RD. A Peer Recovery Coach Intervention for Hospitalized Patients with Opioid Use Disorder: A Pilot Randomized Controlled Trial. J Addict Med. 2023 Sep-Oct 01; 17(5):604-607.
    View in: PubMed
    Score: 0.128
  5. Pivovarova E, Taxman FS, Boland AK, Smelson DA, Lemon SC, Friedmann PD. Facilitators and barriers to collaboration between drug courts and community-based medication for opioid use disorder providers. J Subst Use Addict Treat. 2023 04; 147:208950.
    View in: PubMed
    Score: 0.126
  6. Stimmel MA, Smelson D, Finlay AK. Moving Beyond the Medication or Psychosocial Treatment Dichotomy to Address the Opioid Epidemic. Psychiatr Serv. 2022 12 01; 73(12):1320-1321.
    View in: PubMed
    Score: 0.120
  7. Taylor EN, Timko C, Binswanger IA, Harris AHS, Stimmel M, Smelson D, Finlay AK. A national survey of barriers and facilitators to medications for opioid use disorder among legal-involved veterans in the Veterans Health Administration. Subst Abus. 2022; 43(1):556-563.
    View in: PubMed
    Score: 0.115
  8. Finlay AK, Harris AHS, Timko C, Yu M, Smelson D, Stimmel M, Binswanger IA. Disparities in Access to Medications for Opioid Use Disorder in the Veterans Health Administration. J Addict Med. 2021 04 01; 15(2):143-149.
    View in: PubMed
    Score: 0.111
  9. Morse E, Binswanger IA, Taylor E, Gray C, Stimmel M, Timko C, Harris AHS, Smelson D, Finlay AK. Strategies to improve implementation of medications for opioid use disorder reported by veterans involved in the legal system: A qualitative study. J Subst Abuse Treat. 2021 10; 129:108353.
    View in: PubMed
    Score: 0.111
  10. Finlay AK, Morse E, Stimmel M, Taylor E, Timko C, Harris AHS, Smelson D, Yu M, Blue-Howells J, Binswanger IA. Barriers to Medications for Opioid Use Disorder Among Veterans Involved in the Legal System: a Qualitative Study. J Gen Intern Med. 2020 09; 35(9):2529-2536.
    View in: PubMed
    Score: 0.105
  11. Hanna J, Kubiak S, Pasman E, Gaba A, Andre M, Smelson D, Pinals DA. Evaluating the implementation of a prisoner re-entry initiative for individuals with opioid use and mental health disorders: Application of the consolidated framework for implementation research in a cross-system initiative. J Subst Abuse Treat. 2020 01; 108:104-114.
    View in: PubMed
    Score: 0.098
  12. Finlay AK, Binswanger IA, Timko C, Smelson D, Stimmel MA, Yu M, Bowe T, Harris AHS. Facility-level changes in receipt of pharmacotherapy for opioid use disorder: Implications for implementation science. J Subst Abuse Treat. 2018 12; 95:43-47.
    View in: PubMed
    Score: 0.093
  13. Smelson DA, Roy A, Roy M. The electroretinogram and neuropsychological functioning in cocaine addicts. Can J Psychiatry. 1996 Aug; 41(6):415.
    View in: PubMed
    Score: 0.080
  14. Finlay AK, Harris AH, Rosenthal J, Blue-Howells J, Clark S, McGuire J, Timko C, Frayne SM, Smelson D, Oliva E, Binswanger I. Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients. Drug Alcohol Depend. 2016 Mar 01; 160:222-6.
    View in: PubMed
    Score: 0.078
  15. Gonzalez G, DiGirolamo G, Romero-Gonzalez M, Smelson D, Ziedonis D, Kolodziej M. Memantine improves buprenorphine/naloxone treatment for opioid dependent young adults. Drug Alcohol Depend. 2015 Nov 01; 156:243-253.
    View in: PubMed
    Score: 0.076
  16. Smelson DA, Dixon L, Craig T, Remolina S, Batki SL, Niv N, Owen R. Pharmacological treatment of schizophrenia and co-occurring substance use disorders. CNS Drugs. 2008; 22(11):903-16.
    View in: PubMed
    Score: 0.044
  17. Jasuja GK, Bettano A, Smelson D, Bernson D, Rose AJ, Byrne T, Berlowitz DR, McCullough MB, Miller DR. Homelessness and Veteran Status in Relation to Nonfatal and Fatal Opioid Overdose in Massachusetts. Med Care. 2021 04 01; 59(Suppl 2):S165-S169.
    View in: PubMed
    Score: 0.028
  18. Midboe AM, Byrne T, Smelson D, Jasuja G, McInnes K, Troszak LK. The Opioid Epidemic In Veterans Who Were Homeless Or Unstably Housed. Health Aff (Millwood). 2019 08; 38(8):1289-1297.
    View in: PubMed
    Score: 0.025
  19. Roy M, Roy A, Williams J, Weinberger L, Smelson D. Reduced blue cone electroretinogram in cocaine-withdrawn patients. Arch Gen Psychiatry. 1997 Feb; 54(2):153-6.
    View in: PubMed
    Score: 0.021
  20. Roy M, Smelson D, Roy A. Longitudinal study of blue cone retinal function in cocaine-withdrawn patients. Biol Psychiatry. 1997 Jan 15; 41(2):252-3.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.